Breaking News

Takeda To Acquire Paradigm Therapeutics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Takeda Pharmaceutical Co. Ltd. has entered an agreement to acquire Paradigm Therapeutics Ltd. Paradigm will become a subsidiary of Takeda Europe Holdings B.V., and will be renamed Takeda Cambridge Ltd., while its subsidiary in Singapore will be renamed Takeda Singapore Pte Ltd. The transaction is expected to close within the next few weeks. Financial terms were not disclosed. Paradigm has target identification and validation capabilities based on genetic engineering and in vivo pharmacology...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters